Assessing the risk of blood clots in hospitalized patients in community hospitals
Chinese Community Inpatient Thromboembolism: a Cross-sectional Study
This study is trying to see how likely hospitalized patients in community hospitals are to develop blood clots and hopes to create a new way to predict and prevent these clots.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1152 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | RenJi Hospital Academic / other |
| Locations | 2 sites (Shanghai, Shanghai and 1 other locations) |
| Trial ID | NCT06168331 on ClinicalTrials.gov |
What this trial studies
This multicenter observational study collects data from inpatients at 20 community hospitals to evaluate the risk of venous thromboembolism (VTE). It gathers information on demographics, co-morbidities, medications, and laboratory tests, and uses established risk assessment tools to stratify patients based on their VTE risk. The study also aims to develop a new VTE risk score tailored for community hospitalized patients, enhancing the prediction and prevention of VTE. Blood samples will be analyzed to assess coagulation function, and color Doppler ultrasound will be used for VTE screening.
Who should consider this trial
Good fit: Ideal candidates for this study are inpatients at community service centers who can provide informed consent.
Not a fit: Patients who are outpatients or those who do not agree to participate in the study will not benefit from this research.
Why it matters
Potential benefit: If successful, this study could lead to improved VTE risk assessment and prevention strategies for hospitalized patients, potentially reducing the incidence of blood clots.
How similar studies have performed: Other studies have shown success in using risk assessment tools for VTE, but the development of a community-specific risk score is a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Inpatients in community service centers * Patients or guardians agree with the study plan and sign the informed consent. Exclusion Criteria: * Outpatients in community service centers * The patient or guardian does not agree to sign the informed consent.
Where this trial is running
Shanghai, Shanghai and 1 other locations
- Department of Pharmacy, Renji Hospital, Shanghai Jiao Tong University School of Medicine — Shanghai, Shanghai, China (Active_not_recruiting)
- Department of Pharmacy, Renji Hospital, Shanghai Jiao Tong University School of Medicine — Shanghai, Shanghai, China (Recruiting)
Study contacts
- Study coordinator: Meng Hu, PhD
- Email: humeng@renji.com
- Phone: +86 15000090636
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.